Viewing Study NCT02558816


Ignite Creation Date: 2025-12-26 @ 11:48 AM
Ignite Modification Date: 2026-02-25 @ 8:58 PM
Study NCT ID: NCT02558816
Status: COMPLETED
Last Update Posted: 2025-07-24
First Post: 2015-08-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of Obinutuzumab,GDC-0199 Plus Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma Patients
Sponsor: Nantes University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module